// App-Quantinova.ai

: Assessment of Romiplostim Immunogenicity in Adult Patients in Clinical Trials and in a Global Registry

Researchers

Presenter

  • Troy E. Barger

Principal Investigators

  • Andy Boshier

  • Vibha Jawa

  • June Kim

  • Daniel T. Mytych

  • Joseph Park

  • David J. Kuter

Medical Centers

  • Amgen Inc, Thousand Oaks, CA

  • Amgen, Ltd., Uxbridge, United Kingdom

  • Merck & Co., Inc., Kenilworth, NJ

  • Division of Hematology, Massachusetts General Hospital, Harvard University, Boston, MA

Locations

  • United States

  • United Kingdom

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Romiplostim

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved